Physician profile
Kyle Koelker
NPI 1619535366
$386.48
in general payments reported to CMS, 2019-2025
10 companies · $215 in 2025
The $215 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.48 · 2022: $23.31 · 2023: $33.78 · 2024: $37.44 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $106.08 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $76.48 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $39.36 | 2025 | |
| Orthofix Medical, INC. | $38.24 | 2025 | Physio-Stim |
| Axogen | $29.35 | 2025 | |
| Davol INC. | $23.57 | 2025 | Arista |
| Ethicon US, LLC | $23.31 | 2022 | |
| Puma Biotechnology, INC. | $20.81 | 2023 | |
| Fidia Pharma USA INC. | $16.31 | 2024 | Triluron, Hymovis, Hyalgan |
| Depuy Synthes Sales INC. | $12.97 | 2023 | Orthovisc, Monovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Koelker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.